8-K Announcements
6Material company update
May 1, 2026·SEC
Material company update
Mar 20, 2026·SEC
Material company update
Dec 17, 2025·SEC
Natural Alternatives International, Inc.(NAII)Earnings, Financials & Key Ratios
NAII•NASDAQ
Price updated Jun 19, 2026
AboutNatural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.Show more
- Revenue$130M+14.1%
- EBITDA-$4M-5.5%
- Net Income-$14M-88.1%
- EPS (Diluted)-2.28-85.4%
- Gross Margin7.15%+18.6%
- EBITDA Margin-3.16%+7.6%
- Operating Margin-6.67%+11.1%
- Net Margin-10.45%-64.8%
- ROE-17.98%-113.4%
NAII Key Insights
Natural Alternatives International, Inc. (NAII) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.2x book value
✗Weaknesses
- ✗Profits declining 52.5% over 5 years
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NAII posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NAII Price & Volume
Natural Alternatives International, Inc. (NAII) stock price & volume — 10-year historical chart
Loading chart...
NAII Growth Metrics
Natural Alternatives International, Inc. (NAII) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.03%
5 Years1.78%
3 Years-8.76%
TTM12.36%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-74.55%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-69.67%
Return on Capital
10 Years7.91%
5 Years3.49%
3 Years-3.11%
Last Year-6.61%
NAII Recent Earnings
Natural Alternatives International, Inc. (NAII) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 18, 2026Metric
Actual
Est
EPS
$0.72
—
Rev
$35M
—
Q1 2026
Feb 13, 2026Metric
Actual
Est
EPS
$0.42
—
Rev
$35M
—
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.05
—
Rev
$34M
—
Q4 2025
Sep 23, 2025Metric
Actual
Est
EPS
$0.17
—
Rev
$34M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 18, 2026 | $0.72 | $35M |
| Q1 2026 | Feb 13, 2026 | $0.42 | $35M |
| Q4 2025 | Nov 12, 2025 | $0.05 | $34M |
| Q4 2025 | Sep 23, 2025 | $0.17 | $34M |
Based on last 12 quarters of dataView full earnings history →
NAII Peer Comparison
Natural Alternatives International, Inc. (NAII) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NATR | 353.81M | 20.12 | 18.98 | 5.67% | 4.06% | 12.08% | 0.12 | |
 MGPI | 351.34M | 16.44 | -3.29 | -23.77% | -45.97% | -32.05% | 0.37 | |
 USNA | 348.47M | 18.88 | 32.55 | 8.28% | 1.16% | 1.84% | 0.02 | |
 HLF | 1.23B | 11.90 | 5.41 | 0.89% | 4.67% | |||
 PLNT | 4.21B | 52.98 | 20.22 | 12.06% | 16.52% | |||
 NNBR | 147.24M | 2.79 | -2.61 | -9.06% | -8.03% | -22.93% | 1.44 | |
 VITL | 446.05M | 10.41 | 7.23 | 25.26% | 6.1% | 14.47% | 0.15 | |
 AMZN | 2.63T | 244.39 | 34.09 | 12.38% | 12.22% | 23.34% | 0.37 |
Compare NAII vs Peers
Natural Alternatives International, Inc. (NAII) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NAII Income Statement
Natural Alternatives International, Inc. (NAII) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 121.95M | 132.44M | 138.29M | 118.88M | 178.52M | 170.97M | 154.01M | 113.8M | 129.86M | 140.99M |
Revenue Growth % | 6.78% | 8.6% | 4.42% | -14.04% | 50.17% | -4.23% | -9.91% | -26.11% | 14.12% | 12.36% |
Cost of Goods Sold | 95.74M | 106.12M | 114.72M | 100M | 148.08M | 140.46M | 135.86M | 106.93M | 120.57M | 131.07M |
COGS % of Revenue | 78.51% | 80.13% | 82.95% | 84.13% | 82.95% | 82.15% | 88.21% | 93.97% | 92.85% | - |
Gross Profit | 26.2M▲ 0% | 26.32M▲ 0.4% | 23.57M▼ 10.4% | 18.87M▼ 20.0% | 30.44M▲ 61.3% | 30.51M▲ 0.2% | 18.16M▼ 40.5% | 6.87M▼ 62.2% | 9.29M▲ 35.3% | 9.93M▲ 0% |
Gross Margin % | 21.49% | 19.87% | 17.05% | 15.87% | 17.05% | 17.85% | 11.79% | 6.03% | 7.15% | 7.04% |
Gross Profit Growth % | 3.75% | 0.44% | -10.43% | -19.95% | 61.32% | 0.22% | -40.48% | -62.19% | 35.31% | - |
Operating Expenses | 16.5M | 16.79M | 17.61M | 20.38M | 16.77M | 16.83M | 13.45M | 15.4M | 17.95M | 18.03M |
OpEx % of Revenue | 13.53% | 12.68% | 12.74% | 17.14% | 9.39% | 9.84% | 8.73% | 13.53% | 13.82% | - |
Selling, General & Admin | 16.5M | 16.79M | 17.61M | 18.38M | 16.77M | 16.95M | 14.87M | 15.4M | 16.55M | 16.69M |
SG&A % of Revenue | 13.53% | 12.68% | 12.74% | 15.46% | 9.39% | 9.91% | 9.65% | 13.53% | 12.74% | - |
Research & Development | 1.6M | 1.5M | 1.8M | 1.8M | 1.9M | 2.5M | 2.1M | 1.9M | 1.8M | 3.6M |
R&D % of Revenue | 1.31% | 1.13% | 1.3% | 1.51% | 1.06% | 1.46% | 1.36% | 1.67% | 1.39% | - |
Other Operating Expenses | -19K | -14K | 5K | 200K | -1.9M | -2.62M | -3.52M | -1.9M | -400K | -1.4M |
Operating Income | 9.7M▲ 0% | 9.53M▼ 1.7% | 5.96M▼ 37.5% | -1.51M▼ 125.3% | 13.67M▲ 1006.0% | 13.68M▲ 0.1% | 4.71M▼ 65.5% | -8.53M▼ 281.1% | -8.66M▼ 1.5% | -8.1M▲ 0% |
Operating Margin % | 7.96% | 7.2% | 4.31% | -1.27% | 7.66% | 8% | 3.06% | -7.5% | -6.67% | -5.74% |
Operating Income Growth % | -20.85% | -1.74% | -37.47% | -125.31% | 1006.03% | 0.05% | -65.55% | -281.07% | -1.48% | - |
EBITDA | 12.09M | 12.44M | 9.43M | 2.45M | 18.01M | 20.59M | 11.79M | -3.89M | -4.1M | -3.41M |
EBITDA Margin % | 9.91% | 9.39% | 6.82% | 2.06% | 10.09% | 12.05% | 7.66% | -3.42% | -3.16% | -2.42% |
EBITDA Growth % | -13.86% | 2.94% | -24.23% | -74.01% | 635.1% | 14.34% | -42.73% | -132.96% | -5.48% | 26.44% |
D&A (Non-Cash Add-back) | 2.38M | 2.91M | 3.46M | 3.96M | 4.34M | 6.91M | 7.08M | 4.65M | 4.56M | 4.69M |
EBIT | 10.11M | 12.43M | 7.98M | 491K | 12.24M | 13.74M | 4.01M | -9.1M | -7.26M | -6.7M |
Net Interest Income | 456K | 1.08M | 1.84M | 110K | -117K | -83K | -418K | -185K | -747K | -859K |
Interest Income | 459K | 1.08M | 1.87M | 177K | 1K | 0 | 33K | 176K | 168K | 73K |
Interest Expense | 3K | 9K | 29K | 67K | 118K | 83K | 451K | 361K | 915K | 932K |
Other Income/Expense | 409K | 1.08M | 1.99M | -229K | -1.55M | -20K | -1.16M | -930K | -2.08M | -1.49M |
Pretax Income | 10.11M▲ 0% | 10.61M▲ 5.0% | 7.95M▼ 25.1% | -1.74M▼ 121.9% | 12.13M▲ 797.6% | 13.66M▲ 12.7% | 3.56M▼ 74.0% | -9.46M▼ 366.2% | -10.74M▼ 13.5% | -9.59M▲ 0% |
Pretax Margin % | 8.29% | 8.01% | 5.75% | -1.46% | 6.79% | 7.99% | 2.31% | -8.32% | -8.27% | -6.8% |
Income Tax | 2.88M | 5.56M | 1.41M | -93K | 1.36M | 2.95M | 1.03M | -2.25M | 2.83M | 4.78M |
Effective Tax Rate % | 28.44% | 52.41% | 17.75% | 5.35% | 11.19% | 21.58% | 29.06% | 23.74% | -26.4% | -49.85% |
Net Income | 7.24M▲ 0% | 5.05M▼ 30.2% | 6.54M▲ 29.5% | -1.65M▼ 125.1% | 10.77M▲ 754.6% | 10.71M▼ 0.5% | 2.52M▼ 76.5% | -7.22M▼ 386.2% | -13.57M▼ 88.1% | -14.37M▲ 0% |
Net Margin % | 5.93% | 3.81% | 4.73% | -1.38% | 6.03% | 6.27% | 1.64% | -6.34% | -10.45% | -10.19% |
Net Income Growth % | -24.21% | -30.19% | 29.5% | -125.15% | 754.59% | -0.52% | -76.46% | -386.16% | -88.1% | -74.55% |
Net Income (Continuing) | 7.24M | 5.05M | 6.54M | -1.65M | 10.77M | 10.71M | 2.52M | -7.22M | -13.57M | -14.37M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 1.09▲ 0% | 0.73▼ 33.0% | 0.92▲ 26.0% | -0.25▼ 127.2% | 1.69▲ 776.0% | 1.74▲ 3.0% | 0.43▼ 75.3% | -1.23▼ 386.0% | -2.28▼ 85.4% | -2.39▲ 0% |
EPS Growth % | -24.31% | -33.03% | 26.03% | -127.17% | 776% | 2.96% | -75.29% | -386.05% | -85.37% | -69.67% |
EPS (Basic) | 1.10 | 0.76 | 0.96 | -0.25 | 1.71 | 1.75 | 0.43 | -1.23 | -2.28 | - |
Diluted Shares Outstanding | 6.66M | 6.89M | 7.1M | 6.7M | 6.38M | 6.16M | 5.88M | 5.87M | 5.95M | 6.03M |
Basic Shares Outstanding | 6.58M | 6.64M | 6.81M | 6.7M | 6.29M | 6.12M | 5.86M | 5.87M | 5.95M | 6.03M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NAII Balance Sheet
Natural Alternatives International, Inc. (NAII) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 51.7M | 65.18M | 71.39M | 79.02M | 80.35M | 76.75M | 57.01M | 61.61M | 59.28M | 63.99M |
Cash & Short-Term Investments | 27.84M | 23.61M | 25.04M | 30.48M | 32.13M | 21.83M | 13.6M | 11.98M | 12.32M | 9.2M |
Cash Only | 27.84M | 23.61M | 25.04M | 30.48M | 32.13M | 21.83M | 13.6M | 11.98M | 12.32M | 9.2M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 8.67M | 14.62M | 16.86M | 17.85M | 19.04M | 17.49M | 7.33M | 16.89M | 14.92M | 20.59M |
Days Sales Outstanding | 25.95 | 40.3 | 44.51 | 54.8 | 38.93 | 37.34 | 17.36 | 54.18 | 41.94 | 46.91 |
Inventory | 13.73M | 23.57M | 26M | 27.97M | 27.01M | 32.48M | 29.69M | 24.25M | 24.87M | 29.93M |
Days Inventory Outstanding | 52.34 | 81.06 | 82.74 | 102.09 | 66.57 | 84.39 | 79.78 | 82.77 | 75.29 | 82.77 |
Other Current Assets | 0 | 1.55M | 1.98M | 450K | 0 | 3.14M | 6.38M | 8.49M | 7.16M | 4.28M |
Total Non-Current Assets | 20.91M | 20.02M | 22.1M | 41.18M | 39.93M | 69.26M | 77.14M | 100.73M | 92.66M | 90.89M |
Property, Plant & Equipment | 18.14M | 19.29M | 21.09M | 39.88M | 38.15M | 66.27M | 74.21M | 95.75M | 91.94M | 89.94M |
Fixed Asset Turnover | 6.72x | 6.87x | 6.56x | 2.98x | 4.68x | 2.58x | 2.08x | 1.19x | 1.41x | 1.55x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78K | 0 | 0 |
Other Non-Current Assets | 774K | 202K | 1K | 1.11M | 1.57M | 2.98M | 2.58M | 4.91M | 719K | 942K |
Total Assets | 72.61M▲ 0% | 85.21M▲ 17.3% | 93.49M▲ 9.7% | 120.2M▲ 28.6% | 120.28M▲ 0.1% | 146M▲ 21.4% | 134.15M▼ 8.1% | 162.34M▲ 21.0% | 151.94M▼ 6.4% | 154.88M▲ 0% |
Asset Turnover | 1.68x | 1.55x | 1.48x | 0.99x | 1.48x | 1.17x | 1.15x | 0.70x | 0.85x | 0.91x |
Asset Growth % | -2.11% | 17.35% | 9.72% | 28.57% | 0.06% | 21.38% | -8.12% | 21.01% | -6.41% | -10.94% |
Total Current Liabilities | 10.27M | 14.28M | 14.25M | 27.81M | 22.07M | 23.89M | 15.88M | 23.46M | 28.8M | 39.13M |
Accounts Payable | 5.12M | 9.65M | 8.63M | 12.51M | 11.89M | 16.18M | 7.78M | 12.74M | 15.35M | 18.16M |
Days Payables Outstanding | 19.5 | 33.19 | 27.47 | 45.66 | 29.32 | 42.06 | 20.9 | 43.49 | 46.47 | 48.84 |
Short-Term Debt | 0 | 0 | 0 | 10M | 0 | 302K | 312K | 3.7M | 2.21M | 12.67M |
Deferred Revenue (Current) | 0 | 0 | 0 | 62K | 1.72M | 140K | 317K | 0 | 1.36M | 3.89M |
Other Current Liabilities | 1.21M | 787K | 1.22M | 1.01M | 5.4M | 3.67M | 2.25M | 393K | 4.14M | 6.97M |
Current Ratio | 5.03x | 4.56x | 5.01x | 2.84x | 3.64x | 3.21x | 3.59x | 2.63x | 2.06x | 1.64x |
Quick Ratio | 3.70x | 2.91x | 3.18x | 1.84x | 2.42x | 1.85x | 1.72x | 1.59x | 1.19x | 0.87x |
Cash Conversion Cycle | 58.79 | 88.17 | 99.78 | 111.24 | 76.18 | 79.67 | 76.24 | 93.46 | 70.75 | 80.85 |
Total Non-Current Liabilities | 1.19M | 2.68M | 3.16M | 21.02M | 18.13M | 33.59M | 29.5M | 56.28M | 54.71M | 52.65M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 9.49M | 9.21M | 8.93M | 8.63M | 8.39M |
Capital Lease Obligations | 0 | 0 | 0 | 18.78M | 16.48M | 21.41M | 18.96M | 46.47M | 45.97M | 180.22M |
Deferred Tax Liabilities | 0 | 532K | 1.02M | 0 | 0 | 1.22M | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1.19M | 2.68M | 2.14M | 2.24M | 1.65M | 1.46M | 1.33M | 881K | 111K | 149K |
Total Liabilities | 11.46M | 16.96M | 17.41M | 48.83M | 40.2M | 57.48M | 45.38M | 79.75M | 83.51M | 91.77M |
Total Debt | 0 | 0 | 0 | 28.78M | 16.48M | 31.84M | 30.93M | 60.29M | 59.03M | 65.17M |
Net Debt | -27.84M | -23.61M | -25.04M | -1.7M | -15.65M | 10.01M | 17.33M | 48.31M | 46.7M | 55.97M |
Debt / Equity | - | - | - | 0.40x | 0.21x | 0.36x | 0.35x | 0.73x | 0.86x | 1.03x |
Debt / EBITDA | - | - | - | 11.75x | 0.92x | 1.55x | 2.62x | - | - | -19.12x |
Net Debt / EBITDA | -2.30x | -1.90x | -2.66x | -0.69x | -0.87x | 0.49x | 1.47x | - | - | -16.42x |
Interest Coverage | 3371.33x | 1381.44x | 275.24x | 7.33x | 103.75x | 165.57x | 8.88x | -25.22x | -7.93x | -7.19x |
Total Equity | 61.15M▲ 0% | 68.25M▲ 11.6% | 76.08M▲ 11.5% | 71.38M▼ 6.2% | 80.08M▲ 12.2% | 88.52M▲ 10.5% | 88.77M▲ 0.3% | 82.59M▼ 7.0% | 68.43M▼ 17.2% | 63.11M▲ 0% |
Equity Growth % | 13.81% | 11.61% | 11.48% | -6.19% | 12.2% | 10.54% | 0.28% | -6.96% | -17.15% | -63.99% |
Book Value per Share | 9.19 | 9.91 | 10.72 | 10.66 | 12.55 | 14.38 | 15.10 | 14.07 | 11.51 | 10.47 |
Total Shareholders' Equity | 61.15M | 68.25M | 76.08M | 71.38M | 80.08M | 88.52M | 88.77M | 82.59M | 68.43M | 63.11M |
Common Stock | 79K | 85K | 87K | 87K | 88K | 89K | 91K | 93K | 93K | 94K |
Retained Earnings | 45.79M | 50.84M | 57.38M | 56.18M | 66.95M | 77.66M | 80.18M | 72.97M | 59.39M | 52.24M |
Treasury Stock | -6.07M | -6.58M | -7.96M | -11.7M | -15.85M | -21.35M | -22.86M | -23.08M | -23.25M | -23.34M |
Accumulated OCI | -905K | -578K | 292K | -1.18M | -561K | 1.7M | -83K | -22K | -1.42M | 15K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAII Cash Flow Statement
Natural Alternatives International, Inc. (NAII) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 14.14M | 1.83M | 6.56M | 3.69M | 20.81M | 11.87M | 7.02M | -1.5M | 5.93M | -4.5M |
Operating CF Margin % | 11.59% | 1.38% | 4.75% | 3.1% | 11.65% | 6.94% | 4.56% | -1.32% | 4.57% | - |
Operating CF Growth % | 52.26% | -87.03% | 258.1% | -43.77% | 463.7% | -42.97% | -40.85% | -121.33% | 496.26% | -17060.07% |
Net Income | 7.24M | 5.05M | 6.54M | -1.65M | 10.77M | 10.71M | 2.52M | -7.22M | -13.57M | -14.37M |
Depreciation & Amortization | 2.38M | 2.91M | 3.46M | 3.96M | 4.34M | 4.17M | 4.25M | 4.65M | 4.56M | 4.7M |
Stock-Based Compensation | 1.03M | 1.33M | 1.67M | 1.71M | 1.43M | 968K | 1.01M | 1.2M | 977K | 532K |
Deferred Taxes | 349K | 2.39M | 212K | -893K | -214K | 751K | -974K | -2.91M | 3.61M | 0 |
Other Non-Cash Items | 220K | 526K | 190K | 6.19M | 3.4M | 2.7M | 1.44M | 6.13M | 8.78M | 4.89M |
Working Capital Changes | 2.92M | -10.38M | -5.52M | -5.63M | 1.08M | -7.43M | -1.23M | -3.35M | 1.57M | -7.18M |
Change in Receivables | 4.81M | -6.21M | -1.34M | -4.32M | -813K | 644K | 11.82M | -9.87M | 2.25M | -8.94M |
Change in Inventory | 7.04M | -9.84M | -2.44M | -1.97M | 966K | -5.47M | 2.78M | 5.45M | -622K | -2.94M |
Change in Payables | -7.43M | 4.06M | -183K | 0 | 0 | 3.06M | -8.61M | 5.39M | 2.86M | 4.48M |
Cash from Investing | -5.33M | -5.55M | -3.81M | -4.51M | -5.04M | -26.46M | -13.47M | -3.02M | -3.61M | -4.52M |
Capital Expenditures | -5.35M | -4.08M | -5.33M | -4.54M | -5.11M | -26.49M | -13.52M | -3.02M | -3.61M | -4.52M |
CapEx % of Revenue | 4.39% | 3.08% | 3.85% | 3.82% | 2.86% | 15.49% | 8.78% | 2.65% | 2.78% | 3.21% |
Acquisitions | 25K | 28K | 19K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 25K | -1.47M | 1.5M | 35K | 68K | 30K | 57K | 0 | 0 | 0 |
Cash from Financing | -712K | -510K | -1.33M | 6.25M | -14.11M | 4.29M | -1.78M | 2.89M | -1.97M | 7.61M |
Debt Issued (Net) | 0 | 0 | 0 | 10M | -10M | 9.79M | -278K | 3.11M | -1.8M | 7.7M |
Equity Issued (Net) | -712K | -510K | -1.37M | -3.75M | -4.11M | -5.5M | -1.5M | -221K | -178K | -89K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -712K | -510K | -1.37M | -3.75M | -4.15M | -5.5M | -1.5M | -221K | -178K | -89K |
Other Financing | 0 | 0 | 38K | 0 | 35K | 0 | 0 | 0 | 0 | 0 |
Net Change in Cash | 8.1M▲ 0% | -4.23M▼ 152.2% | 1.43M▲ 133.7% | 5.44M▲ 281.1% | 1.66M▼ 69.6% | -10.3M▼ 722.4% | -8.23M▲ 20.1% | -1.62M▲ 80.3% | 344K▲ 121.2% | -1.42M▲ 0% |
Free Cash Flow | 8.78M▲ 0% | -2.25M▼ 125.6% | 1.24M▲ 155.0% | -850K▼ 168.7% | 15.7M▲ 1946.9% | -14.62M▼ 193.1% | -6.5M▲ 55.5% | -4.51M▲ 30.6% | 2.32M▲ 151.4% | -9.02M▲ 0% |
FCF Margin % | 7.2% | -1.7% | 0.89% | -0.71% | 8.79% | -8.55% | -4.22% | -3.97% | 1.79% | -6.4% |
FCF Growth % | 859.78% | -125.59% | 155.03% | -168.71% | 1946.94% | -193.14% | 55.51% | 30.61% | 151.35% | -171.56% |
FCF per Share | 1.32 | -0.33 | 0.17 | -0.13 | 2.46 | -2.38 | -1.11 | -0.77 | 0.39 | -1.50 |
FCF Conversion (FCF/Net Income) | 1.95x | 0.36x | 1.00x | -2.24x | 1.93x | 1.11x | 2.78x | 0.21x | -0.44x | 0.63x |
Interest Paid | 0 | 9K | 23K | 66K | 131K | 206K | 802K | 285K | 814K | 333K |
Taxes Paid | 2.89M | 1.82M | 1.97M | 993K | 2.96M | 2.61M | 1.84M | 463K | 323K | 373K |
NAII Key Ratios
Natural Alternatives International, Inc. (NAII) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 12.6% | 7.81% | 9.06% | -2.23% | 14.22% | 12.71% | 2.84% | -8.42% | -17.98% | -21.48% |
Return on Invested Capital (ROIC) | 21.63% | 18.35% | 9.35% | -1.88% | 15.29% | 12.59% | 3.45% | -5.4% | -5.28% | -4.27% |
Gross Margin | 21.49% | 19.87% | 17.05% | 15.87% | 17.05% | 17.85% | 11.79% | 6.03% | 7.15% | 7.04% |
Net Margin | 5.93% | 3.81% | 4.73% | -1.38% | 6.03% | 6.27% | 1.64% | -6.34% | -10.45% | -10.19% |
Debt / Equity | - | - | - | 0.40x | 0.21x | 0.36x | 0.35x | 0.73x | 0.86x | 1.03x |
Interest Coverage | 3371.33x | 1381.44x | 275.24x | 7.33x | 103.75x | 165.57x | 8.88x | -25.22x | -7.93x | -7.19x |
FCF Conversion | 1.95x | 0.36x | 1.00x | -2.24x | 1.93x | 1.11x | 2.78x | 0.21x | -0.44x | 0.63x |
Revenue Growth | 6.78% | 8.6% | 4.42% | -14.04% | 50.17% | -4.23% | -9.91% | -26.11% | 14.12% | 12.36% |
Related:NAII Dividend History·NAII Revenue History·NAII Price History·NAII P/E History·NAII Financial Ratios·NAII Institutional Holders
NAII SEC Filings & Documents
Natural Alternatives International, Inc. (NAII) SEC filings — annual & quarterly reports (10-K, 10-Q)
NAII Frequently Asked Questions
Natural Alternatives International, Inc. (NAII) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Natural Alternatives International, Inc. (NAII) reported $141.0M in revenue for fiscal year 2024. This represents a 196% increase from $47.6M in 1995.
Natural Alternatives International, Inc. (NAII) grew revenue by 14.1% over the past year. This is steady growth.
Natural Alternatives International, Inc. (NAII) reported a net loss of $14.4M for fiscal year 2024.
Dividend & Returns
Natural Alternatives International, Inc. (NAII) has a return on equity (ROE) of -18.0%. Negative ROE indicates the company is unprofitable.
Natural Alternatives International, Inc. (NAII) had negative free cash flow of $9.0M in fiscal year 2024, likely due to heavy capital investments.